Compounds of formula (I):
wherein R
1
, R
2
, R
3
, R
4
, R
5
, Z and n have defined meanings, the N-oxide forms, the pharmaceutically acceptable addition salts, the quaternary ammonium salts and the stereochemically isomeric forms thereof, and their use for the treatment of PARP-mediated disorders.